Genomtec (WAR:GMT) Debt-to-Revenue : 1.75 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genomtec Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Genomtec's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was zł0.85 Mil. Genomtec's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was zł1.01 Mil. Genomtec's annualized Revenue for the quarter that ended in Mar. 2024 was zł1.06 Mil. Genomtec's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 1.75.

Genomtec Debt-to-Revenue Historical Data

The historical data trend for Genomtec's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Debt-to-Revenue Chart

Genomtec Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

3.27

51.65

7.97

57.20

1,988.00

Genomtec Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial												3.20	N/A	528.50	N/A	1.75

Competitive Comparison of Genomtec's Debt-to-Revenue

For the Medical Devices subindustry, Genomtec's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomtec's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genomtec's Debt-to-Revenue falls into.

Genomtec Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Genomtec's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.878	+	1.11)	/	0.001
	=	1,988.00

Genomtec's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.854	+	1.011)	/	1.064
	=	1.75

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

Genomtec Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genomtec's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomtec (WAR:GMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

4VI:Germany

Address

ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066

Website

http://www.genomtec.com

Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines